About Medical Technology Partners

It is Medical Technology Partners' mission to accelerate the rate of trial and acceptance of important new medical technologies, thereby enabling them to reach patients more quickly.

Medical Technology Partners helps companies understand and work with the new reimbursement realities within the health care marketplace by way of reasonable and functional strategies and plans. MTP is committed to excellent customer service, advancing patient care, making timely and accurate recommendations, and reasonable and flexible pricing arrangements.

Medical Technology Partners will enhance the development of important new medical technologies by providing high quality and fully integrated reimbursement support services to the medical industry, with an emphasis on medical device and diagnostic technologies.

President.  Jerry Stringham has spent much of the past sixteen years as a reimbursement strategy consultant. Beginning in December 1988, Mr. Stringham began providing reimbursement consulting to diverse medical and pharmaceutical companies. Mr. Stringham holds a BS in Mechanical Engineering from the Massachusetts Institute of Technology and an MBA from Harvard Business School. He has been part of five medical device start-up organizations operating out of New England. Mr. Stringham founded Medical Technology Partners in 1998 to fill the growing need for business-oriented reimbursement consulting. Mr. Stringham's experience in industry, including as a Principal in the health economics practice of a major CRO, brings expertise to new technology reimbursement challenges.

Recent Presentations

September 2002 - Massachusetts Medical Device Industry Council (Mass Medic) Reimbursement Committee Meeting. "Medicare payment update - Hospital Outpatient Prospective Payment System."

May 2002 - Medical Device Manufacturer's Association (MDMA) Annual Meeting. "Integrating coverage and reimbursement into your company's strategic plan."

October 2001 – BIO. “Reimbursement and business development planning for new medical technologies.”

July 2001 – AdvaMed Technology Conference. “Removing key barriers to gaining new medical technology trial and acceptance ¼ the impact of the FDA, Medicare and the intellectual property reform.”

May 2001 – Health Care Financing Administration. “Impact on the change from ICD-9 to ICD-10 on new medical technology” before the ICD-9 Coding Committee.

May 2001 – Medical Device Manufacturer’s Association (MDMA) Annual Meeting. “The impact of the new inpatient hospital reimbursement system on medical device manufacturers.”

In the News

April 2002 – The Gray Sheet article "CMS should calculate 2003 OPPS update using clinical trial cost data."

August 2001 – FDA News interview with Jerry Stringham, Stephan Hull and Randall Richner concerning the Impact of the Health Care Financing Administration’s name change to the Centers for Medicare and Medicaid Services.

June 2001 – Medical Device and Diagnostic Industry Report article “Industry expert suggests HCFA implementation of BIPA for inpatient services does not meet congressional mandate – urges medical device industry to reject HCFA proposal."